T-CELL DEPLETED AUTO STEM CELL TRANPLANT FOR SSC
$494,890N01FY2000ARNIH
University Of Pittsburgh At Pittsburgh, Pittsburgh PA
Investigators
Linked publications & trials
Abstract
This is a pilot, open label-clinical trial designed to test the toxicity and potential efficacy of a new immunoablative and bone marrow suppressive combination regimen prior (preparative phase) to stem cell transplantation in patients with rapidly progressing cutaneous scleroderma.
View original record on NIH RePORTER →